BR112012006835A2 - inibidores macrocíclicos da replicação do vírus de hepatite c - Google Patents

inibidores macrocíclicos da replicação do vírus de hepatite c

Info

Publication number
BR112012006835A2
BR112012006835A2 BR112012006835A BR112012006835A BR112012006835A2 BR 112012006835 A2 BR112012006835 A2 BR 112012006835A2 BR 112012006835 A BR112012006835 A BR 112012006835A BR 112012006835 A BR112012006835 A BR 112012006835A BR 112012006835 A2 BR112012006835 A2 BR 112012006835A2
Authority
BR
Brazil
Prior art keywords
virus replication
replication inhibitors
macrocyclic hepatitis
horizontal flat
macrocyclic
Prior art date
Application number
BR112012006835A
Other languages
English (en)
Inventor
Brad Buckman
John B Nicholas
Scott D Seiwert
Vladimir Serebryany
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BR112012006835A2 publication Critical patent/BR112012006835A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035—Isoindoles, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic

Abstract

tela basal para aperfeiçoamento de crescimento de biomassa de algas. a presente invenção refere-se a uma grade tridimensional para uso como superfície de crescimento de grama de alga contém uma rede basal plana horizontal contendo uma série de elementos planos horizontais e elementos direcionados para cima.
BR112012006835A 2009-09-28 2010-09-24 inibidores macrocíclicos da replicação do vírus de hepatite c BR112012006835A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24646509P 2009-09-28 2009-09-28
US32425110P 2010-04-14 2010-04-14
PCT/US2010/050284 WO2011038283A1 (en) 2009-09-28 2010-09-24 Novel macrocyclic inhibitors of hepatitis c virus replication

Publications (1)

Publication Number Publication Date
BR112012006835A2 true BR112012006835A2 (pt) 2016-06-07

Family

ID=43796239

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012006835A BR112012006835A2 (pt) 2009-09-28 2010-09-24 inibidores macrocíclicos da replicação do vírus de hepatite c

Country Status (12)

Country Link
US (1) US20110129444A1 (pt)
EP (1) EP2483273A4 (pt)
JP (1) JP2013505951A (pt)
KR (1) KR20120110090A (pt)
CN (1) CN102712644A (pt)
AR (1) AR078461A1 (pt)
BR (1) BR112012006835A2 (pt)
CA (1) CA2774387A1 (pt)
MX (1) MX2012003171A (pt)
RU (1) RU2012117395A (pt)
TW (1) TW201124136A (pt)
WO (1) WO2011038283A1 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2305695A3 (en) 2005-07-25 2011-07-27 Intermune, Inc. Macrocyclic inhibitors of Hepatitis C virus replication
BRPI0617274A2 (pt) * 2005-10-11 2011-07-19 Intermune Inc compostos e métodos para a inibição de replicação viral de hepatite c
BRPI0911260A2 (pt) * 2008-04-15 2015-09-29 Intermune Inc composto, composição farmacêutica, método de inibição de atividade da protease de ns3/ns4 in, vitro e usos de compostos
KR20110075019A (ko) * 2008-10-15 2011-07-05 인터뮨, 인크. 치료용 항바이러스성 펩티드
AR075584A1 (es) 2009-02-27 2011-04-20 Intermune Inc COMPOSICIONES TERAPEUTICAS QUE COMPRENDEN beta-D-2'-DESOXI-2'-FLUORO-2'-C-METILCITIDINA Y UN DERIVADO DE ACIDO ISOINDOL CARBOXILICO Y SUS USOS. COMPUESTO.
WO2011041551A1 (en) * 2009-10-01 2011-04-07 Intermune, Inc. Therapeutic antiviral peptides
US8957203B2 (en) 2011-05-05 2015-02-17 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
CN103562199B (zh) * 2011-05-27 2016-03-30 百时美施贵宝公司 作为丙型肝炎病毒抑制剂的掺入氘的三肽
US8691757B2 (en) 2011-06-15 2014-04-08 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
PT2909205T (pt) 2012-10-19 2017-02-06 Bristol Myers Squibb Co Derivados de carbamato de hexadecahidrociclopropa(e)pirrolo(1,2- a)(1,4)diazaciclopentadecinilo substituídos com 9-metilo como inibidores da protease não estrutural 3 (ns3) para o tratamento de infeções por vírus da hepatite c
US9334279B2 (en) 2012-11-02 2016-05-10 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
US9643999B2 (en) 2012-11-02 2017-05-09 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
US9598433B2 (en) 2012-11-02 2017-03-21 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
US9409943B2 (en) 2012-11-05 2016-08-09 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
JP6342922B2 (ja) 2013-03-07 2018-06-13 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ Ｃ型肝炎ウイルス阻害剤

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5149820A (en) * 1987-03-11 1992-09-22 Norsk Hydro A.S. Deuterated compounds
KR20040068613A (ko) * 1994-03-25 2004-07-31 이소테크니카 인코포레이티드 중수소화된 화합물 이를 포함하는 고혈압 치료용 조성물
US6334997B1 (en) * 1994-03-25 2002-01-01 Isotechnika, Inc. Method of using deuterated calcium channel blockers
US6376531B1 (en) * 1998-11-13 2002-04-23 Rupert Charles Bell Method of treatment using deuterium compounds
DE10129832A1 (de) * 2001-06-17 2003-07-10 Berolina Drug Dev Ab Svedala Deuterierte N- und alpha-substituierte Diphenylalkoxyessigsäureaminoalkylester sowie diese Verbindungen enthaltende Arzneimittel
DE10162121A1 (de) * 2001-12-12 2003-06-18 Berolina Drug Dev Ab Svedala Deuterierte substituierte Pyrazolyl-Benzolsulfonamide sowie diese Verbindungen enthaltende Arzneimittel
CA2481449A1 (en) * 2002-04-26 2003-11-06 Gilead Sciences, Inc. Method and compositions for identifying anti-hiv therapeutic compounds
WO2004096285A2 (en) * 2003-04-25 2004-11-11 Gilead Sciences, Inc. Anti-infective phosphonate conjugates
RS20060259A (en) * 2003-10-14 2008-08-07 Intermune Inc., Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of hcv replication
EA012389B1 (ru) * 2004-03-30 2009-10-30 Интермун, Инк. Макроциклические соединения в качестве ингибиторов вирусной репликации
UA91677C2 (ru) * 2004-03-30 2010-08-25 Интермюн, Инк. Макроциклические соединения как ингибиторы вирусной репликации
DE102004033312A1 (de) * 2004-07-08 2006-01-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Kontinuierliches Metatheseverfahren mit Ruthenium-Katalysatoren
EP2305695A3 (en) * 2005-07-25 2011-07-27 Intermune, Inc. Macrocyclic inhibitors of Hepatitis C virus replication
US20090155209A1 (en) * 2007-05-03 2009-06-18 Blatt Lawrence M Novel macrocyclic inhibitors of hepatitis c virus replication
US20090047252A1 (en) * 2007-06-29 2009-02-19 Gilead Sciences, Inc. Antiviral compounds
CA2692145C (en) * 2007-06-29 2015-03-03 Gilead Sciences, Inc. Antiviral compounds
JP2011503231A (ja) * 2007-11-20 2011-01-27 コンサート ファーマシューティカルズ インコーポレイテッド Ｈｃｖ感染処置のためのペプチド
KR101629523B1 (ko) * 2007-12-21 2016-06-10 에프. 호프만-라 로슈 아게 대환 화합물의 제조방법
BRPI0911260A2 (pt) * 2008-04-15 2015-09-29 Intermune Inc composto, composição farmacêutica, método de inibição de atividade da protease de ns3/ns4 in, vitro e usos de compostos
WO2010048468A1 (en) * 2008-10-23 2010-04-29 Concert Pharmaceuticals, Inc. Deuterated macrocyclic inhibitors of viral ns3 protease
TW201111381A (en) * 2009-06-23 2011-04-01 Gilead Sciences Inc Pharmaceutical combinations useful for treating HCV
US20100324059A1 (en) * 2009-06-23 2010-12-23 Gilead Sciences, Inc. Pharmaceutical compositions useful for treating hcv
US20100324060A1 (en) * 2009-06-23 2010-12-23 Gilead Sciences, Inc. Pharmaceutical compositions useful for treating hcv

Also Published As

Publication number Publication date
EP2483273A4 (en) 2013-05-01
JP2013505951A (ja) 2013-02-21
AR078461A1 (es) 2011-11-09
MX2012003171A (es) 2012-04-11
CN102712644A (zh) 2012-10-03
TW201124136A (en) 2011-07-16
KR20120110090A (ko) 2012-10-09
RU2012117395A (ru) 2013-11-10
EP2483273A1 (en) 2012-08-08
WO2011038283A1 (en) 2011-03-31
US20110129444A1 (en) 2011-06-02
CA2774387A1 (en) 2011-03-31

Similar Documents

Publication Publication Date Title
BR112012006835A2 (pt) inibidores macrocíclicos da replicação do vírus de hepatite c
WO2011038413A3 (en) Basal screen for enhancing algal biomass growth
HK1226096A1 (zh) 產生藻類細胞培養及藻類生物量、脂質化合物及組合物，以及相關產品的方法
ZA201507731B (en) Methods and compositions for generating chondrocyte lineage cells and/or cartilage like tissue
PH12017501445A1 (en) Methods for producing virus for vaccine production
MX339939B (es) Generacion de plantas haploides y cruza de plantas mejorada.
MX2022008149A (es) Replica de carne que comprende un indicador del progreso de coccion.
MX345643B (es) Cubierta médica.
ZA201400368B (en) Methods and compositions for producing male sterile plants
UY34100A (es) INMUNOCONJUGADOS DEL PROFARMACO seco-MGBA, COMPOSICIONES Y MÉTODOS PARA PREPARARLOS, Y SUS USOS
CR20130676A (es) Composiciones de lipidos algales y metodos para prepararlas y utilizarlas
GB201000593D0 (en) Photo-bioreactor and method for cultivating biomass by photosynthesis
EP2674025A4 (en) CULTURE MEDIUM FOR PLANT CULTURE
EP2571959A4 (en) METHOD FOR PRODUCTION OF HYDROGEN HYGIENIC CARBON PRODUCTS
IL218073A0 (en) Cultivation of tamarix tree for biomass fuel
BR112016029950A2 (pt) corpo vegetal ideal para plantação de alta densidade e uso do mesmo
BR112014018032A2 (pt) método para produzir uma composição
UY33949A (es) Procedimiento para producir semilla f1 de arroz, semilla f1 de arroz y línea macho estéril de arroz
HUE049334T2 (hu) Eljárás és berendezés biogáz elõállítására lignocellulóz-tartalmú biomasszából
EP2854513A4 (en) METHOD FOR THE LARGE PRODUCTION OF AN ARTIFICIAL SEED PRODUCT WITH SYMBIOTICS
EP2806728A4 (en) CARBON CANNULAR MANUFACTURING METHOD FOR STIMULATING MICROORGANISMS AND PLANT GROWTH PRODUCED FROM THE EMISSIONS OF A COMBUSTION ENGINE
UY34516A (es) ?compuestos reguladores del crecimiento vegetal; intermedios para prepararlos; composiciones; métodos para controlar crecimiento de plantas y/o potenciar germinación de semillas?.
CO7380750A2 (es) Proceso para producir un alimento de rosetas de maíz compactadas y alimento producido mediante dicho proceso
ZA201603961B (en) Bioreactor for in vitro plant culture
EP2542249A4 (en) METHOD AND COMPOSITIONS FOR SUPPORTING TISSUE INTEGRATION AND INOCULATION OF TRANSPLANTED TISSUE AND TRANSPLANTED TREATED PENIS FABRIC WITH FAT FABRIC ACETIC COSTS

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]